Objective: To make a prospective assessment of the clinical and prognostic correlates of angiographically diffuse non-obstructive coronary lesions. Design: Angiographic vessel and extent scores were calculated in 228 clinically stable patients (mean (SD) age, 60 (11) years; 43 women, 185 men) undergoing prospective follow up for the composite end point of death and myocardial infarction. The effect on outcome of clinical variables (age, sex, previous myocardial infarction, diabetes mellitus, smoking habit, systemic hypertension, hypercholesterolaemia, ejection fraction) and angiographic variables (vessel and extent score) was evaluated by Cox's proportion hazard model. Results: The vessel score was 3 in 34 patients (15%), 2 in 78 (34%), 1 in 87 (38%), and 0 in 29 (13%). Median extent score was 60 (range 6-110; first quartile 40, third quartile 70). Forty one events (nine deaths and 32 myocardial infarcts) occurred over a median follow up period of 30 months. Age and extent score were the only multivariate predictors of outcome, but the latter provided 28% additional prognostic information after adjustment for the most predictive variables (gain in χ 2 = 7, p < 0.01). A vessel score of 3 was associated with worse survival, while no significant discrimination was possible among the other groups. However, assignment of patients to two groups according to an ROC curve derived cut off value for the extent score made it possible to obtain significant discrimination of survival even in cases with vessel scores of 0 to 2. Age and diabetes were clinical markers of a higher extent score. Conclusions: The angiographic extent score is a powerful marker of adverse outcome independent of severity and the number of flow limiting coronary lesions, and may reflect the link between clinical risk profile and diffusion of coronary atherosclerosis. Thus it should be of clinical value for targeting aggressive preventive measures.
T he severity of coronary artery disease, the site of stenoses, and the number of diseased vessels are known to influence prognosis, particularly with regard to cardiac mortality. 1 The severity of coronary artery stenoses shown by angiograms is most commonly measured as per cent diameter narrowing relative to the normal lumen size adjacent to the stenotic segment. However, coronary atherosclerosis is usually diffuse and the normal reference segment is frequently narrowed as well. 2 3 Moreover, serial segmental narrowing, representing a commonly encountered type of diffuse disease, is not accounted for by simple percentage narrowing because of absence of a true normal reference segment, or methods of quantifying the cumulative effects of multiple stenoses. Thus information on seemingly milder, non-obstructive lesions may often be missed and their prognostic importance underestimated. On the other hand, it is known that plaque rupture or erosion with superimposed occlusive thrombosis, underlying acute coronary syndromes or sudden death, often occurs at sites of less than 50% diameter stenoses. [4] [5] [6] [7] Some years ago the extent score was proposed, 8 to quantify the proportion of coronary endothelial surface area affected by atheroma. We have used this score to quantify the proportion of the coronary circulation involved by atheroma and have sought to assess its clinical and prognostic correlates prospectively.
METHODS

Study population
The initial study population consisted of 439 clinically stable patients undergoing diagnostic coronary angiography on the basis of clinical or non-invasive stress test data and with prospective follow up. Of these, 211 were revascularised by means of either bypass surgery or percutaneous transluminal coronary angioplasty within six months of the index angiography and were excluded from the study to avoid possible referral bias. Thus 228 conservatively managed patients (mean (SD) age, 60 (11) years; 43 women, 185 men) went on with their follow up programme and formed the study population.
Coronary angiography
Selective coronary cineangiography was done from the brachial or femoral approach using Judkin's or Sones's technique. Multiple views were obtained in all patients, with the left anterior descending and left circumflex coronary arteries visualised in at least four views and the right coronary artery in at least two views. All coronary and left ventricular angiograms were interpreted by two experienced observers, and differences in interpretation were resolved by consensus. Degree of stenosis was defined as the greatest percentage reduction of luminal diameter in any view compared with the nearest normal segment (per cent diameter stenosis) and was determined using the calliper technique. 9 The vessel score indicated the number of coronary arteries with > 70% stenosis (> 50% for the left main coronary artery). The extent score was calculated as previously suggested. 8 In brief, any luminal irregularity identifying the segment of vessel involved by atheroma is multiplied by a specific factor for each coronary vessel: 5 for the left main artery; 20 for the left anterior descending artery; 10 for the main diagonal branch; 5 for the first septal perforator; 20 (10 if small) for the left circumflex artery; 10 (20 if large marginal) for obtuse marginal and posterolateral vessels; 20 for the right coronary artery; and 10 for the main posterior descending branch. The numerical sum of the scores obtained for each individual vessel gives the total score, which ranges from 0-100, providing an estimation of the percentage of the coronary surface involved by atheroma. In case of incomplete collateralisation of an occluded vessel, this is assigned the mean extent score of vessels proximal to the occlusion.
The ejection fraction was calculated by means of left ventriculography.
Follow up
Follow up information was obtained by prospectively determined visits at our outpatient clinic, by discharge reports from other hospitals in case of emergency admission, and by telephone interviews with the patient, his close relative, or his referring physician.
Death and myocardial infarction represented the target events of the study. Owing to the difficulty in ascribing a cardiac origin to deaths occurring suddenly, the overall mortality was used as an unbiased and objective end point. 10 11 Myocardial infarction was diagnosed on the basis of documented ECG changes and typical cardiac enzyme release.
Patients undergoing revascularisation were censored at the time of the procedure.
Statistical analysis
Continuous variables are expressed as mean (SD) and were compared by unpaired two sample t tests in case of normal distribution and by the Mann-Whitney test in case of non-normal distribution. Normality was assessed by the Kolmogorov-Smirnov test. The 95% confidence interval (CI) is reported when appropriate. Proportions were compared by χ 2 statistics. The individual effect of clinical and angiographic variables on survival was evaluated by means of Cox's proportional hazard model using a stepwise forward procedure. At each step a significance of 0.1 was required to enter into the model. The χ 2 value was calculated from the log likelihood ratio. A significant increase in global χ 2 of the model after the addition of further variables was considered to indicate incremental prognostic value. Cumulative survival curves as a function of time were generated with the Kaplan-Meier method and compared by the log rank test. The effect of clinical variables on the extent score was assessed by the general linear model univariate procedure, which provides regression analysis and analysis of variance for one dependent variable by one or more independent variables. Statistical significance was settled at a probability value of p < 0.05. The area under a receiver operating characteristic (ROC) curve method 12 was used to select the cut off value of the extent score providing the best discrimination of risk. The Statistical Package for Social Science (SPSS, release 10.0 for Microsoft Windows) was used.
RESULTS
Angiographic findings
The vessel score was 3 in 34 patients (15%), 2 in 78 (34%), 1 in 87 (38%), and 0 in 29 (13%). The left main stem was affected in five patients (2%), the left anterior descending coronary artery in 125 (55%), the circumflex coronary artery in 101 Figure 1 Extent score distribution according to the vessel score. The box extends from the first to the third quartile, with a horizontal line at the median. Whiskers extend down to the smallest value and up to the largest. (44%), and the right coronary artery in 117 (51%). The median extent score was 60 (range 5-110; first quartile 40, third quartile 70). Extent score distribution according to vessel score is shown in fig 1; a variation over a wide range is evident for vessel scores of 1 and 2.
Follow up events
Mean follow up time was 30 months (95% confidence interval, 25 to 32 months). No patient was lost to follow up. Forty one target events occurred (nine deaths and 32 non-fatal myocardial infarcts). Seven of the nine deaths were related to proven cardiac factors (fatal myocardial infarction or acute heart failure), while two occurred suddenly. In addition, 18 patients underwent revascularisation procedures (13 bypass surgery and five coronary angioplasty) at six months or more after the index angiography.
Outcome prediction
The characteristics of the study population according to outcome are shown in table 1. Patients with follow up events were older, more often diabetic, and had significantly higher vessel and extent scores compared with patients without events. Age, diabetes, a vessel score of 3, and extent score were univariate predictors of the cumulative end point of death and myocardial infarction, but only age and extent score were also significantly and independently associated with the outcome on multivariate analysis (table 2) . After adjustment for the most predictive variables, the extent score provided 28% additional prognostic information (gain in χ 2 = 7, p < 0.01).
Survival analysis
Kaplan-Meier event-free survival curves according to vessel and extent score are shown in fig 2. A vessel score of 3 was associated with a significantly worse survival (log rank χ 2 for trend = 4.5, p = 0.027), but the overlap between group 1 and group 2 did not allow further prognostic classification. Conversely, the event rate increased significantly across ascending quartiles of extent score, providing a continuum for risk stratification. ROC curve analysis indicated 60 as the cut off value of extent score giving the best discrimination of risk (area under the curve = 0.70). The assignment of patients to two groups according to this value allowed significant discrimination of the event rate, even in cases with vessel scores of 0 to 2 (fig 3) . This demonstrated the additional prognostic value of the extent score over the vessel score. In particular, six of the seven events occurring among the 29 patients with a vessel score of 0 were associated with extent score of > 60 and only one with an extent score of < 60 (χ 2 = 4.8, p = 0.02; relative risk 8 (95% CI 1.2 to 57)).
Clinical correlates of extent score
The correlation between extent score and clinical variables is shown in table 3; age and diabetes were the only significant discriminators of a higher extent score.
DISCUSSION
The results of this study show that the diffusion of coronary atherosclerosis, assessed by the angiographic extent score, is a strong and independent predictor of adverse outcome, capable of providing additional prognostic information compared with clinical variables and the simple number of vessels with flow limiting stenoses. The calculation of per cent luminal diameter narrowing and the consequent classification of coronary artery disease according to the number of vessels showing flow limiting stenoses traditionally represents the preferred method of scoring coronary artery disease severity in both angiographic and prognostic 13 14 studies. Although providing a convenient scheme in clinical practice, this method is limiting in that it includes patients with very different risk profiles and underestimates the importance of the overall coronary anatomy. 15 The poor correlation between angiographic severity of coronary stenoses and the subsequent occurrence and location of vessel occlusion has been reported previously. 16 It later became evident that most plaque ruptures or erosions complicated by occlusive thrombosis and resulting in acute coronary syndromes or sudden death occur at sites involving less than 50% lumen diameter narrowing. 6 7 On the other hand, patients with non-occlusive lesions have significantly more cardiovascular events than those with truly normal angiograms. 17 Recent studies showed that a sudden increase in pre-existing coronary stenoses, often associated with obvious changes in plaque morphology, can precede the onset of acute coronary syndromes 18 19 and that the occurrence of acute myocardial infarction cannot be predicted from the severity of preexisting stenoses. 20 Unfortunately, serial angiographic studies showed that the progression of coronary artery disease in humans is neither linear nor predictable. 4 New high grade lesions often appear in arterial segments that were normal only few months earlier, thus providing an explanation for the sudden progression of mild atherosclerosis to acute coronary events.
It has long been known that the angiographic severity of coronary lesions may not be the best reflection of the atherosclerotic process and its prognostic correlates. 21 Ledru and colleagues sought to identify the angiographic predictors of future cardiac events and found that stenosis severity predicted only infarcts occurring within one year of angiography. 22 Thus the identification of coronary lesions at high risk of occlusion remains challenging. 23 At present there are few data on the morphology of vulnerable plaque in clinical settings and their prevalence in the general population. Yamagishi and colleagues reported that large eccentric plaques with features of a lipid-rich core can be at increased risk of instability even though the lumen area is preserved. 24 Moreover, compensatory enlargement of the vessel wall because of remodelling 25 26 can increase the risk of plaque rupture and acute luminal narrowing, although in this case angiography suggests a relatively small degree of stenosis with consequent underestimation of disease severity.
The extent score was significantly correlated with age and the presence of diabetes in our study. This is in keeping with the known pivotal role of diabetes as both a promoter of atherogenesis 27 and as a prognostic determinant of cardiac morbidity and mortality. 28 The extent score may thus reflect the chronically progressive component of atherosclerotic disease in the coronary circulation, which is not adequately addressed by angiographic variables that are simply related to stenosis severity.
Clinical implications
It is a major challenge in modern cardiology to develop a diagnostic method for identifying vulnerable plaques that could guide the physician in targeting intervention techniques to prevent acute vessel occlusion. Currently available tools do not allow one to identify serial changes marking the transition from stable to unstable plaques in humans, and from a disrupted plaque to an occlusive thrombus. Thus the evaluation of coronary artery disease severity remains the angiographic benchmark for patient management. 29 The results of our study suggest that the extent score is a powerful marker of the risk of hard events independent of severity and even of the presence of flow limiting coronary lesions, and may reflect the link between clinical risk profile and diffusion of coronary atherosclerosis. Thus it could be of clinical value for targeting aggressive prevention measures whose beneficial effects on the progression and regression of coronary artery disease have been documented in clinical and angiographic studies. [30] [31] [32] The non-invasive quantification of coronary artery calcification by electron beam computed tomography has recently been shown to provide important prognostic information and to be superior to coronary angiography in predicting future cardiac events. 33 This finding is in keeping with our results and emphasises the close correlation between diffusion of coronary atherosclerosis and the likelihood of cardiac events. However, the angiographic assessment of vessel disease in that study relied only on per cent diameter narrowing; thus no correlation could be derived between invasive and noninvasive evaluation of the diffusion of coronary atherosclerosis.
Study limitations
As quantitative angiography was not available in all cases, the calliper technique was used for angiographic analysis; however, the diagnostic performance of the two techniques is known to be similar. 9 Information on the haemodynamic importance of coronary stenosis by stress testing techniques was not evaluated. Finally, this study was conducted in patients who had coronary artery disease but in whom revascularisation was deferred. They therefore represent a lower risk population, and so our results cannot be extrapolated to other higher risk populations. 
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A 59 year old man was admitted after an episode of syncope. There were no ictal features and no relevant past medical history or family history. Examination was unremarkable. His resting ECG showed first degree heart block. Over the next four months he had multiple normal investigations including 24 hour ECG recording, electroencephalogram, cranial computed tomography, tilt testing, and carotid Doppler ultrasound. During this period he had two further episodes of syncope. He was therefore admitted for insertion of an implantable loop recorder (ILR) (Reveal Plus, Medtronic). That evening he suffered a further syncopal episode, and interrogation of the ILR revealed complete heart block with prolonged pauses (below left). A dual chamber permanent pacing system was implanted above the ILR, which was left in situ. He had no further episodes of syncope following this procedure, but developed episodic palpitations. ECGs demonstrated paroxysmal atrial fibrillation (PAF). Sotalol failed to control the PAF, so flecainide was substituted. The patient continued to suffer occasional palpitations. Interrogation of the ILR revealed episodes of torsade de pointes ventricular tachycardia (below right). Flecainide was therefore discontinued, and his PAF has been successfully controlled with bisoprolol. No further episodes of torsade de pointes have occurred. Generally, the ILR is removed at the time of pacemaker insertion if a bradyarrhythmia is recorded. As the cost of the device is mainly at implantation, there may be a rationale for leaving the ILR in situ after pacemaker insertion to ensure no additional diagnoses are missed.
